Stay updated on GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe webpage has been updated to include new results and metrics related to CD8+ T cell density and pathologic complete response rates in tumor tissue, while some previous results and metrics have been removed.SummaryDifference14%
- Check44 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.3%
- Check72 days agoChange DetectedResults have been submitted, replacing the previous status of no results posted.SummaryDifference0.2%
Stay in the know with updates to GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.